Avelios Medical
PrivateLast Round
Strategic
Oct 20, 2026
Total Funding Raised
$36.12M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Avelios Medical operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Strategic round in May 2026.
Avelios Medical is a healthtech company that provides a modular, AI-native hospital information system designed to digitize and optimize clinical and administrative workflows.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Medical AI, Workflow Automation, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelios Medical Comparables
Compare Avelios Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Meierhofer AG | 81% | |
| Lunar | 78% | |
| NEXUS AG | 74% |
For institutional investors. Book with your work email.
Avelios Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 20, 2026 | ||||
| Strategic | May 6, 2026 | ||||
| Early Funding | Feb 25, 2026 | ||||
| Series A | Feb 6, 2025 | ||||
| Grant | Mar 22, 2023 | ||||
Seed | Nov 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Avelios Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Revent Capital | Series A, Seed |
| European Innovation Council Fund | Grant |
| zwei.7 | Series A |
| Sequoia Capital | Series A |
| High-Tech Gründerfonds | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2026
NVIDIA participated in the strategic round.
- Jul 26, 2026
Monthly visitors increased 56% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 20, 2026
Avelios Medical GmbH is developing an A.I.-native hospital information system that unifies clinical and administrative workflows to free up doctors and nurses, with Sana Kliniken, LMU Hospital Munich, and Hannover Medical School among its customers.
For institutional investors. Book with your work email.
Avelios Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Avelios Medical's valuation, stock price, and market status.
Is Avelios Medical a public or private company?
Avelios Medical is a private company.
What is the current stock price of Avelios Medical?
Avelios Medical is a private company, so its shares have no public market price. Caplight tracks Avelios Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Avelios Medical worth (valuation)?
Valuation information for Avelios Medical is not publicly available.
Can I buy Avelios Medical stock?
Avelios Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Avelios Medical's last funding round?
Avelios Medical's most recent funding round was Strategic on October 20, 2026.
Who are the main investors in Avelios Medical?
Key investors in Avelios Medical include Revent Capital, Sequoia Capital.
Will Avelios Medical IPO soon?
No public IPO plans have been announced for Avelios Medical.
How can I track Avelios Medical secondary market activity?
Caplight tracks bids, offers, and trades in Avelios Medical's shares on secondary markets.